Skip to main content

Table 1 Baseline characteristics of deaths from MNFGO in Shanghai PNA, 1995–2018

From: Years of life lost due to premature death and their trends in people with malignant neoplasm of female genital organs in Shanghai, China during 1995–2018: a population based study

Site Deaths (N, %) Age in years (Mean ± SD) Age in years (Median) CMR (/105) ASMRW (/105) YLL (years) YLL rate (/105)
Vulva cancer (C51) 71 (2.47) 77.50 ± 11.32 79.12 0.23 0.09 661.58 2.13
Vagina cancer (C52) 40 (1.39) 69.15 ± 12.58 70.43 0.13 0.06 518.42 1.67
Cervix uteri cancer (C53) 677 (23.60) 63.51 ± 16.86 62.59 2.18 1.14 10,272.51 33.04
Corpus uteri cancer (C54) 293 (10.21) 67.72 ± 11.88 67.65 0.94 0.47 4007.61 12.89
Uterus unspecified cancer (C55) 471 (16.42) 69.41 ± 14.14 70.38 1.15 0.72 6075.53 19.54
Ovary cancer (C56) 1260 (43.92) 62.86 ± 13.54 62.08 4.05 2.23 19,763.83 63.56
Other female genital organs cancer (C57) 56 (1.95) 65.56 ± 10.03 66.01 0.18 0.10 826.37 2.66
Placenta cancer (C58) 1 (0.03) 28.17 28.17 0.00 0.00 26.98 0.09
Total 2869 (100.00) 65.08 ± 14.59 64.92 9.23 4.8 42,152.82 135.56
  1. ASMRW Age-standardized mortality rate by Segi’s world standard population, CMR Crude mortality rate, PNA Pudong New Area, YLL Years of life lost, MNFGO Malignant neoplasm of female genital organs